Boris Komyakov
Impact in
Papers in
-
- Ureteral procedures and complications 19
- Urology 15
- Urological Disorders and Treatments 13
- Co-authors
- Nassim Morsli (1 shared paper)Lisa Sengeløv (1 shared paper)Joaquim Bellmunt (1 shared paper)Agnieszka Irena Jagiełło-Gruszfeld (1 shared paper)Eric Winquist (1 shared paper)Hans von der Maase (1 shared paper)Oleg Karyakin (1 shared paper)Patrick Hurteloup (1 shared paper)
In The Last Decade
Boris Komyakov
43 papers receiving 1.2k citations
Boris Komyakov's Hit Papers
Peers
Comparison fields: 5 of 65
- Surgery 833
- Oncology 407
- Urology 64
- Obstetrics and Gynecology 41
- Pulmonary and Respiratory Medicine 145
Countries citing papers authored by Boris Komyakov
This map shows the geographic impact of Boris Komyakov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Komyakov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Komyakov more than expected).
Fields of papers citing papers by Boris Komyakov
This network shows the impact of papers produced by Boris Komyakov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Komyakov. The network helps show where Boris Komyakov may publish in the future.
Co-authors
The 25 scholars most cited alongside Boris Komyakov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract Hit paper breakdown → | 2009 | 611 |
| 2 | Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2020 | 400 |
| 3 | 2016 | 27 | |
| 4 | 2018 | 21 | |
| 5 | 2020 | 16 | |
| 6 | 2025 | 15 | |
| 7 | 2023 | 12 | |
| 8 | 2014 | 11 | |
| 9 | 2017 | 11 | |
| 10 | 2020 | 9 | |
| 11 | 2019 | 4 | |
| 12 | 2020 | 4 | |
| 13 | 2022 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2020 | 3 | |
| 16 | 2021 | 3 | |
| 17 | 2016 | 3 | |
| 18 | [Results of open and laparoscopic partial nephrectomy for localized renal cancer]. | 2017 | 3 |
| 19 | 2021 | 3 | |
| 20 | 2020 | 2 |
About Boris Komyakov
Boris Komyakov is a scholar working on Obstetrics and Gynecology, Urology, Pulmonary and Respiratory Medicine, Surgery and Pediatrics, Perinatology and Child Health, having authored 59 papers that have together received 1.2k indexed citations. Recurring topics across this work include Ureteral procedures and complications (19 papers), Urological Disorders and Treatments (13 papers), Kidney Stones and Urolithiasis Treatments (10 papers), Bladder and Urothelial Cancer Treatments (10 papers), Pediatric Urology and Nephrology Studies (9 papers), Renal and Vascular Pathologies (5 papers), Renal cell carcinoma treatment (4 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Surgery (833 citations), Oncology (407 citations), Urology (64 citations), Obstetrics and Gynecology (41 citations) and Pulmonary and Respiratory Medicine (145 citations). Boris Komyakov has collaborated with scholars based in Russia, Sweden and France. Frequent co-authors include Nassim Morsli, Lisa Sengeløv, Joaquim Bellmunt, Agnieszka Irena Jagiełło-Gruszfeld, Eric Winquist, Hans von der Maase, Oleg Karyakin, Patrick Hurteloup, Yacine Salhi and Gedske Daugaard. Their work appears in journals such as The Journal of Urology, Scientific Reports, The Lancet, Journal of Medical Virology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.